BTSG BrightSpring Health Services, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1865782 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY26.0%
TTM net income YoY216.6%
TTM EPS YoY204.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin12.5%
Operating margin3.4%
Net margin2.7%
FCF margin3.2%
EBITDA margin4.5%
Returns
ROE20.5%
ROA6.7%
ROIC (approx.)11.0%
Asset turnover2.48x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity1.00x
Current ratio1.62x
Interest coverage3.59x
Cash quality & payout
Operating cash flow / net income1.47x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $12.91B | $10.07B | $7.69B | $7.72B |
| Gross profit | $1.52B | $1.27B | $1.14B | $1.35B |
| SG&A expense | $1.22B | $1.16B | $1.08B | $1.13B |
| Operating income | $295.25M | $107.95M | $58.12M | $187.83M |
| Interest expense | $157.31M | $190.55M | $271.90M | $233.58M |
| Pretax income | $137.94M | -$95.32M | -$213.77M | -$45.75M |
| Income tax | $33.15M | -$26.39M | -$31.51M | $33.15M |
| Net income | $190.67M | -$18.06M | -$154.60M | -$53.91M |
| EBITDA | $459.53M | $312.44M | $260.46M | $391.80M |
| EPS (basic) | 0.94 | -0.09 | -1.31 | -0.46 |
| EPS (diluted) | 0.87 | -0.09 | -1.31 | -0.46 |
| Weighted avg. shares (diluted) | 219.77M | 193.00M | 117.87M | 117.84M |
| Balance sheet | ||||
| Cash & equivalents | $88.37M | $60.95M | $12.43M | — |
| Receivables | $989.72M | $902.78M | $881.63M | — |
| Inventory | $815.18M | $636.56M | $402.78M | — |
| Current assets | $2.89B | $1.89B | $1.46B | — |
| PP&E, net | $204.69M | $180.57M | $245.91M | — |
| Goodwill | $2.55B | $2.36B | $2.30B | $2.58B |
| Intangibles | $557.55M | $595.22M | $881.48M | — |
| Total assets | $6.41B | $5.93B | $5.53B | — |
| Current liabilities | $1.85B | $1.43B | $1.25B | — |
| Short-term debt | $52.34M | $48.73M | $32.27M | — |
| Long-term debt | $2.46B | $2.56B | $3.33B | — |
| Total debt | $2.51B | $2.61B | $3.36B | — |
| Total liabilities | $4.53B | $4.27B | $4.92B | — |
| Shareholders' equity | $1.88B | $1.65B | $584.74M | $754.78M |
| Net debt | $2.42B | $2.55B | $3.35B | — |
| Shares outstanding | 192.12M | 174.25M | 117.86M | — |
| Cash flow statement | ||||
| Operating cash flow | $490.17M | $23.77M | $210.78M | -$4.65M |
| Capital expenditure | $95.48M | $80.91M | $73.53M | $70.11M |
| Free cash flow | $394.69M | -$57.14M | $137.26M | -$74.77M |
| Investing cash flow | -$305.08M | -$140.24M | -$134.43M | $45.36M |
| Financing cash flow | -$157.87M | $164.65M | -$76.91M | -$73.81M |
| Depreciation & amortization | $164.28M | $204.48M | $202.34M | $203.97M |
| Stock-based compensation | $70.10M | $69.17M | $3.92M | $3.55M |
| Share buybacks | $43.17M | $650,000 | $650,000 | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.